factual
Psychedelic Trials Are Inherently Hard to Blind
It is very hard to keep psychedelic trials blinded because the drugs' effects are so powerful that most participants know they received the active compound—though some guessed wrong in both directions—and this difficulty extends to mental health trials generally, where the endpoint is how patients feel, so a working drug tends to reveal itself.
factualpending
Speaker
Jennifer MitchellEvidence Quote
“it's hard to blind mental health treatment trials in general because what you want is for your drug to work and if your drug does people typically know it”
Created: 6/14/2026, 2:01:41 AM
Your notes
Loading notes...